Concepedia
Statistics
Publications
24
Citations
1.1K
H-Index
18
Active since
2017
Affiliations
Hubei University of Medicine(Current)
Wuhan University
Wuhan Donghu University
Taihe Hospital
Hubei Provincial Center for Disease Control and Prevention
Tong‐Fei Li is an author at Hubei University of Medicine specializing in oncology, nanomedicine, and cancer nanomedicine.
Publications per year
2017–2025
Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma
Tong‐Fei Li, Ke Li, Quan Zhang et al. · Biomaterials · 2018 · 127 citations
Life Sciences, Immunology, Oncology +16
Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment
Tong‐Fei Li, Ke Li, Chao Wang et al. · Journal of Controlled Release · 2017 · 94 citations
Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy
Ning Han, Ziyi Yang, Zhong-Xiong Xie et al. · Phytomedicine · 2023 · 89 citations
Life Sciences, Molecular Biology, Oncology +17
A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin
Xiaoxin Yang, Xiang Xu, Meifang Wang et al. · Journal of Nanobiotechnology · 2022 · 86 citations · Full text
Medicine, Oncology, Pharmacology +17
Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy
Tong‐Fei Li, Yong‐Hong Xu, Ke Li et al. · Acta Biomaterialia · 2019 · 82 citations
Life Sciences, Cancer Biology, Oncology +14
1–5 of 24